Literature DB >> 23068975

Wound modulation after filtration surgery.

Leonard K Seibold1, Mark B Sherwood, Malik Y Kahook.   

Abstract

Filtration surgery is the standard invasive procedure for the management of intraocular pressure in advanced glaucoma. The key to a successful outcome is to modulate the normal wound healing cascade that leads to closure of the newly created aqueous outflow pathway. Antifibrotic agents such as mitomycin C and 5-fluorouracil have been increasingly used to modulate the wound healing process and increase surgical success. Although these agents have proven efficacy, they also increase the risk of complications. Efforts have centered on the identification of novel agents and techniques that can influence wound modulation without these complications. We detail new agents and methods under investigation to control wound healing after filtration surgery.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23068975     DOI: 10.1016/j.survophthal.2012.01.008

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  41 in total

1.  Safety and efficacy of photodynamic therapy using BCECF-AM compared to mitomycin C in controlling post-operative fibrosis in a rabbit model of subscleral trabeculectomy.

Authors:  Azza Mohamed Ahmed Said; Rania Gamal Eldin Zaki; Thanaa Helmy Mohamed; Manal Ibraheem Salman
Journal:  Int J Ophthalmol       Date:  2016-03-18       Impact factor: 1.779

Review 2.  Angiogenesis in glaucoma filtration surgery and neovascular glaucoma: A review.

Authors:  Megan Kim; Chelsea Lee; Rachael Payne; Beatrice Y J T Yue; Jin-Hong Chang; Hongyu Ying
Journal:  Surv Ophthalmol       Date:  2015-05-15       Impact factor: 6.048

3.  Changes in the morphology of the hyperemic blebs in eyes undergone trabeculectomy with mitomycin C after injection of triamcinolone acetonide during one-year follow-up.

Authors:  Zakieh Vahedian; Ghasem Fakhraie; Marzye Faraji; Seyed Mehdi Tabatabaei
Journal:  Int Ophthalmol       Date:  2021-06-25       Impact factor: 2.031

4.  Preliminary results of antiscarring therapy in the prevention of postendoscopic esophageal mucosectomy strictures.

Authors:  Yuhsin Wu; Steve J Schomisch; Cassandra Cipriano; Amitabh Chak; Richard H Lash; Jeffrey L Ponsky; Jeffrey M Marks
Journal:  Surg Endosc       Date:  2013-10-08       Impact factor: 4.584

5.  Functional evaluation of the filtering bleb by ultrasound biomicroscopy after trabeculectomy with mitomycin C.

Authors:  Ali Abbas El Salhy; Rabab Mohamed Elseht; Ahmed Fekry Al Maria; Saied Mohamed Abd El-Wahab Shalaby; Tarek Ragaee Hossein
Journal:  Int J Ophthalmol       Date:  2018-02-18       Impact factor: 1.779

6.  Outcomes of same-site re-operation with minimal use of mitomycin in failed trabeculectomy.

Authors:  Yadollah Eslami; Vafa Samarai; Massood Mohammadi; Ghasem Fakhraie; Reza Zarei; Sajad Eslami; Sasan Moghimi
Journal:  Int Ophthalmol       Date:  2013-08-14       Impact factor: 2.031

7.  Animal models of scarring control.

Authors:  David L Williams
Journal:  Eye (Lond)       Date:  2019-12-10       Impact factor: 3.775

Review 8.  Standalone XEN45 Gel Stent implantation versus combined XEN45-phacoemulsification in the treatment of open angle glaucoma-a systematic review and meta-analysis.

Authors:  Sheng Yang Lim; Bjorn Kaijun Betzler; Leonard Wei Leon Yip; Syril Dorairaj; Bryan Chin Hou Ang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-04-29       Impact factor: 3.535

9.  Intracameral Bevacizumab Versus Sub-Tenon's Mitomycin C as Adjuncts to Trabeculectomy: 3-Year Results of a Prospective Randomized Study.

Authors:  Gerasimos Kopsinis; Dimitrios Tsoukanas; Dimitra Kopsini; Theodoros Filippopoulos
Journal:  J Clin Med       Date:  2021-05-11       Impact factor: 4.241

10.  The Effect of a Triple Combination of Bevacizumab, Sodium Hyaluronate and a Collagen Matrix Implant in a Trabeculectomy Animal Model.

Authors:  Vanessa Andrés-Guerrero; Irene Camacho-Bosca; Liseth Salazar-Quiñones; Nestor Ventura-Abreu; Mercedes Molero-Senosiain; Samuel Hernández-Ruiz; Guillermo Bernal-Sancho; Rocío Herrero-Vanrell; Julián García-Feijóo
Journal:  Pharmaceutics       Date:  2021-06-17       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.